Key facts
- Notable investors include Plug and Play Tech Center, Groove Capital, Meach Cove Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Vireo Ag
- ·The full record, as it builds
Funding rounds
No funding rounds for Vireo Ag are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vireo Ag
Developer of a genome editing platform designed to accelerate crop improvement by eliminating the need for tissue culture. The company's platform offers in-soil editing, broad crop compatibility, and cost-efficient transformation methods, enabling seed companies, biofuel developers, and researchers to develop higher-yielding, resilient crops with flexibility.
- Sector
- Healthcare
- HQ
- Minneapolis, MN, United States
- Founded
- 2025
- Employees
- 7
- Website
- vireoag.com/
- Ownership
- Privately Held (backing)
Vireo Ag doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vireo Ag shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vireo Ag in its N-PORT filings yet. We sweep new filings monthly.